DE69841989D1 - Verfahren zur Bestimmung von Nukleinsäuresequenzen in Urin - Google Patents
Verfahren zur Bestimmung von Nukleinsäuresequenzen in UrinInfo
- Publication number
- DE69841989D1 DE69841989D1 DE69841989T DE69841989T DE69841989D1 DE 69841989 D1 DE69841989 D1 DE 69841989D1 DE 69841989 T DE69841989 T DE 69841989T DE 69841989 T DE69841989 T DE 69841989T DE 69841989 D1 DE69841989 D1 DE 69841989D1
- Authority
- DE
- Germany
- Prior art keywords
- nucleic acid
- acid sequence
- urine sample
- urine
- acid sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4817097P | 1997-05-30 | 1997-05-30 | |
US4838197P | 1997-06-30 | 1997-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69841989D1 true DE69841989D1 (de) | 2010-12-16 |
Family
ID=26725864
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69833856T Expired - Lifetime DE69833856T2 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur bestimmung von nukleinsäuresequenzen in urin |
DE69841989T Expired - Lifetime DE69841989D1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur Bestimmung von Nukleinsäuresequenzen in Urin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69833856T Expired - Lifetime DE69833856T2 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur bestimmung von nukleinsäuresequenzen in urin |
Country Status (11)
Country | Link |
---|---|
US (2) | US6251638B1 (de) |
EP (3) | EP2216416B1 (de) |
AT (3) | ATE320505T1 (de) |
AU (1) | AU7703998A (de) |
CY (1) | CY1113124T1 (de) |
DE (2) | DE69833856T2 (de) |
DK (3) | DK1634966T3 (de) |
ES (3) | ES2389055T3 (de) |
HK (1) | HK1088363A1 (de) |
PT (1) | PT2216416E (de) |
WO (1) | WO1998054364A1 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451523B1 (en) * | 1994-09-14 | 2002-09-17 | Interneuron Pharmaceuticals, Inc. | Detection of a leptin receptor variant and methods for regulating obesity |
WO1998045420A1 (en) * | 1997-04-10 | 1998-10-15 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
USRE39920E1 (en) * | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
US7060458B1 (en) * | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
US20030170794A1 (en) * | 1997-09-18 | 2003-09-11 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030068731A1 (en) * | 1997-12-17 | 2003-04-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030113842A1 (en) * | 1998-03-11 | 2003-06-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7339033B2 (en) * | 1998-06-26 | 2008-03-04 | Genentech, Inc. | Pro1481 |
US7026448B2 (en) * | 1998-09-01 | 2006-04-11 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU6316100A (en) * | 1999-07-30 | 2001-02-19 | Mitsubishi Pharma Corporation | Gene of human brain type pgt |
JP4018304B2 (ja) * | 1999-08-27 | 2007-12-05 | 独立行政法人科学技術振興機構 | 高親和性コリントランスポーター |
PT1222266E (pt) * | 1999-09-29 | 2006-07-31 | Diagnocure Inc | Arn mensageiro de pca3 em tecidos benignos e malignos da prostata |
EP1201681A1 (de) * | 2000-10-30 | 2002-05-02 | Millennium Pharmaceuticals, Inc. | "Fail" Moleküle und deren Verwendung |
US7029840B2 (en) * | 2000-11-15 | 2006-04-18 | Becton, Dickinson And Company | Method for preservation of cells and nucleic acid targets |
WO2002055985A2 (en) * | 2000-11-15 | 2002-07-18 | Roche Diagnostics Corp | Methods and reagents for identifying rare fetal cells in the material circulation |
WO2002059316A2 (en) * | 2001-01-23 | 2002-08-01 | Lexicon Genetics Incorporated | Human ion exchanger proteins and polynucleotides encoding the same |
US20030144196A1 (en) * | 2001-08-21 | 2003-07-31 | Bowen Michael A. | Activated T lymphocyte nucleic acid sequences and polypeptides encoded by same |
US20030211522A1 (en) * | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
AU2003213107A1 (en) | 2002-02-15 | 2003-09-09 | Exact Sciences Corporation | Methods for analysis of molecular events |
US7217515B2 (en) * | 2002-09-30 | 2007-05-15 | Chi Mei Foundation Medical Center | HURP gene as a molecular marker for bladder cancer |
CA2445204C (en) | 2002-10-16 | 2014-08-12 | Streck Laboratories, Inc. | Method and device for collecting and preserving cells for analysis |
US20050282170A1 (en) | 2003-02-07 | 2005-12-22 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
US20050227225A1 (en) * | 2004-04-07 | 2005-10-13 | Roche Molecular Systems, Inc. | Stabilization of biomolecules in samples |
US20080241827A1 (en) * | 2004-05-10 | 2008-10-02 | Exact Sciences Corporation | Methods For Detecting A Mutant Nucleic Acid |
CN114250299A (zh) | 2004-07-23 | 2022-03-29 | 太平洋边缘有限公司 | 用于膀胱癌检测的尿标记物 |
WO2006026654A2 (en) | 2004-08-27 | 2006-03-09 | Exact Sciences Corporation | Method for detecting a recombinant event |
EP1812601A2 (de) * | 2004-10-22 | 2007-08-01 | Redpath Integrated Pathology, Inc. | Dynamische expansion genomischer deletion und formulierung aus molekularmarkerpanels für integrierte molekulare pathologiediagnose und charakterisierung von gewebe, zellflüssigkeit und reinen flüssigproben |
WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
CA2491067A1 (en) * | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
US7914982B2 (en) | 2005-02-17 | 2011-03-29 | Trovagene, Inc. | Methods for detecting pathogen specific nucleic acids in urine |
ITRM20050067A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine. |
EP2351857B1 (de) | 2005-02-17 | 2014-10-29 | TrovaGene, Inc. | Zusammensetzungen und Verfahren zum Nachweis von für Krankheitserreger spezifischen Nukleinsäuren in Urin |
ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
US7449297B2 (en) * | 2005-04-14 | 2008-11-11 | Euclid Diagnostics Llc | Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays |
WO2007044071A2 (en) * | 2005-04-21 | 2007-04-19 | Exact Sciences Corporation | Analysis of heterogeneous nucleic acid samples |
NZ545243A (en) * | 2006-02-10 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Urine gene expression ratios for detection of cancer |
EP2140027B1 (de) * | 2006-12-07 | 2012-07-18 | Novartis AG | Nichtinvasiver pränataler genetischer screen-test |
WO2008075790A2 (en) * | 2006-12-20 | 2008-06-26 | Olympus Corporation | Method for detecting cancer with nucleic acids in blood |
DK2195450T4 (en) * | 2007-08-22 | 2016-10-24 | Trovagene Inc | Methods of using miRNA FOR DETECTION IN VIVO cell death |
WO2009049147A2 (en) * | 2007-10-10 | 2009-04-16 | Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine | Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine |
CN101999003A (zh) * | 2008-02-12 | 2011-03-30 | 诺瓦蒂斯公司 | 分离无细胞凋亡或胎儿核酸的方法 |
EP2271772B1 (de) * | 2008-03-11 | 2014-07-16 | Sequenom, Inc. | Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung |
EP2853601B1 (de) | 2008-07-18 | 2016-09-21 | TrovaGene, Inc. | Verfahren für den PCR-basierten Nachweis ultrakurzer Nukleinsäuresequenzen |
US8962247B2 (en) * | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
EP3290530B1 (de) | 2009-02-18 | 2020-09-02 | Streck Inc. | Konservierung von zellfreien nukleinsäuren |
ES2571104T3 (es) * | 2009-11-09 | 2016-05-24 | Streck Inc | Estabilización del ARN y extracción del ARN presente en células intactas dentro de una muestra de sangre |
WO2011087760A2 (en) | 2009-12-22 | 2011-07-21 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
EP3378954B1 (de) | 2011-04-29 | 2021-02-17 | Sequenom, Inc. | Quantifizierung einer minderheitsvariante einer nukleinsäure |
WO2012151391A2 (en) | 2011-05-04 | 2012-11-08 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
SG191757A1 (en) | 2011-06-29 | 2013-08-30 | Bgi Health Service Co Ltd | Noninvasive detection of fetal genetic abnormality |
EP4155401A1 (de) | 2012-03-02 | 2023-03-29 | Sequenom, Inc. | Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
CA2878979C (en) | 2012-07-13 | 2021-09-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US9341628B2 (en) | 2012-11-30 | 2016-05-17 | Interpace Diagnostics Corporation | Methods for measuring carcinoembryonic antigen |
WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
WO2015013244A1 (en) | 2013-07-24 | 2015-01-29 | Streck, Inc. | Compositions and methods for stabilizing circulating tumor cells |
EP3117011B1 (de) | 2014-03-13 | 2020-05-06 | Sequenom, Inc. | Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen |
WO2016001411A1 (en) | 2014-07-03 | 2016-01-07 | Multiplicom N.V. | Methods for non-invasive detection of transplant health or rejection |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
WO2018022991A1 (en) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Suspension composition for hematology analysis control |
US11854666B2 (en) | 2016-09-29 | 2023-12-26 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
WO2019236978A1 (en) * | 2018-06-07 | 2019-12-12 | Biofire Diagnostics, Llc | Rapid thermocycling methods |
US11965217B2 (en) * | 2020-07-21 | 2024-04-23 | Delta Electronics, Inc. | Method and kit for detecting Mycobacterium tuberculosis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5541331A (en) | 1991-04-30 | 1996-07-30 | Reilly Industries, Inc. | Processes for producing α-pyridyl carbinols |
ATE198358T1 (de) | 1992-04-27 | 2001-01-15 | Dartmouth College | Detektion von gensequenzen in biologischen flüssigkeiten |
US6020124A (en) * | 1992-04-27 | 2000-02-01 | Trustees Of Dartmouth College | Detection of soluble gene sequences in biological fluids |
US5614402A (en) | 1992-12-07 | 1997-03-25 | Third Wave Technologies, Inc. | 5' nucleases derived from thermostable DNA polymerase |
US5541311A (en) | 1992-12-07 | 1996-07-30 | Third Wave Technologies, Inc. | Nucleic acid encoding synthesis-deficient thermostable DNA polymerase |
WO1997006819A1 (en) * | 1995-08-15 | 1997-02-27 | Alteon Inc. | Compositions and methods for elmination of advanced glycosylation endproducts (in vivo) |
DE19540222A1 (de) * | 1995-10-18 | 1997-04-24 | Horst Dr Schlechte | Verfahren und Vorrichtung zur Gewinnung Personen- und Krankheits-spezifischer Nucleinsäure-Sequenz-Daten |
EP1634890B1 (de) | 1996-01-24 | 2008-11-19 | Third Wave Technologies, Inc. | Invasive Spaltung von Nukleinsäuren |
-
1998
- 1998-05-29 US US09/230,704 patent/US6251638B1/en not_active Expired - Lifetime
- 1998-05-29 EP EP10161334A patent/EP2216416B1/de not_active Expired - Lifetime
- 1998-05-29 ES ES10161334T patent/ES2389055T3/es not_active Expired - Lifetime
- 1998-05-29 AT AT98924998T patent/ATE320505T1/de active
- 1998-05-29 AT AT05077010T patent/ATE486958T1/de active
- 1998-05-29 AT AT10161334T patent/ATE557103T1/de active
- 1998-05-29 DK DK05077010.6T patent/DK1634966T3/da active
- 1998-05-29 AU AU77039/98A patent/AU7703998A/en not_active Abandoned
- 1998-05-29 DK DK98924998T patent/DK0920539T3/da active
- 1998-05-29 DE DE69833856T patent/DE69833856T2/de not_active Expired - Lifetime
- 1998-05-29 DE DE69841989T patent/DE69841989D1/de not_active Expired - Lifetime
- 1998-05-29 WO PCT/US1998/010965 patent/WO1998054364A1/en active IP Right Grant
- 1998-05-29 EP EP98924998A patent/EP0920539B9/de not_active Expired - Lifetime
- 1998-05-29 ES ES98924998T patent/ES2260837T3/es not_active Expired - Lifetime
- 1998-05-29 PT PT10161334T patent/PT2216416E/pt unknown
- 1998-05-29 DK DK10161334.7T patent/DK2216416T3/da active
- 1998-05-29 EP EP05077010A patent/EP1634966B1/de not_active Expired - Lifetime
- 1998-05-29 ES ES05077010T patent/ES2355631T3/es not_active Expired - Lifetime
-
2000
- 2000-07-03 US US09/609,162 patent/US6287820B1/en not_active Expired - Lifetime
-
2006
- 2006-09-14 HK HK06110204.5A patent/HK1088363A1/xx not_active IP Right Cessation
-
2012
- 2012-08-08 CY CY20121100714T patent/CY1113124T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2355631T3 (es) | 2011-03-29 |
DE69833856D1 (de) | 2006-05-11 |
DE69833856T2 (de) | 2006-11-23 |
CY1113124T1 (el) | 2016-04-13 |
ATE320505T1 (de) | 2006-04-15 |
EP2216416B1 (de) | 2012-05-09 |
EP2216416A1 (de) | 2010-08-11 |
WO1998054364A1 (en) | 1998-12-03 |
ES2260837T3 (es) | 2006-11-01 |
US6251638B1 (en) | 2001-06-26 |
EP1634966A2 (de) | 2006-03-15 |
EP1634966A3 (de) | 2006-06-21 |
EP1634966B1 (de) | 2010-11-03 |
EP0920539B1 (de) | 2006-03-15 |
EP0920539A1 (de) | 1999-06-09 |
DK2216416T3 (da) | 2012-08-27 |
US6287820B1 (en) | 2001-09-11 |
ATE486958T1 (de) | 2010-11-15 |
ATE557103T1 (de) | 2012-05-15 |
EP0920539A4 (de) | 2004-06-09 |
AU7703998A (en) | 1998-12-30 |
DK1634966T3 (da) | 2011-02-07 |
HK1088363A1 (en) | 2006-11-03 |
DK0920539T3 (da) | 2006-07-24 |
PT2216416E (pt) | 2012-08-16 |
EP0920539B9 (de) | 2006-08-02 |
ES2389055T3 (es) | 2012-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69841989D1 (de) | Verfahren zur Bestimmung von Nukleinsäuresequenzen in Urin | |
DE69333289D1 (de) | Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien | |
DK1141728T3 (da) | Påvisning af nyresygdom og behandling deraf | |
DE60000583T2 (de) | Verfahren zur identifizierung und/oder quantifizierung einer zielverbindung | |
ATE515693T1 (de) | Nachweis einer zielsubstanz in einer probe | |
DE69433816D1 (de) | Die bestimmung von nukleinsäuremutationen durch analyse des sputum | |
CA2317816A1 (en) | Peptide detection method | |
DK328584D0 (da) | Immunobestemmelsesmetode for en iodthyronin i en biologisk vaeske samt reagenssystem, testsaet og testmateriale til anvendelse ved metoden | |
ATE376595T1 (de) | Nachweisverfahren mit biochip | |
RU2007148219A (ru) | Способ обнаружения бактерий и тест-набор для их обнаружения | |
ATE315107T1 (de) | Verfahren und kit zur früherkennung von krebs | |
WO2001090408A3 (fr) | Detection et caracterisation de l'activite de proteines impliquees dans la reparation de lesions de l'adn | |
DE60012723D1 (de) | Verfahren zur bestimmung von disaccharidasen | |
ATE201769T1 (de) | Verfahren zur kompetitiven bestimmung eines haptens | |
Gillen et al. | Varying oncomodulin mRNA abundance in developing placenta and solid tumors | |
ATE209691T1 (de) | Primer und sonden zur amplifizierung und zum nachweis von cmv nukleinsäure | |
Martin et al. | A comparative study of the citrate and lactate concentrations in stains from semen, vaginal secretion and mixtures of the two using isotachophoresis | |
EP1136568A4 (de) | Methode zum ermitteln der nukleinsäure | |
DE59305225D1 (de) | Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern | |
ATE485515T1 (de) | Verfahren zur diagnose einer person mit multipler sklerose | |
DE60237406D1 (de) | Aus einem Neuroblastom isolierte Nukleinsäuren | |
WO2002018661A3 (en) | Methods for identifying novel therapeutic agents | |
ATE269971T1 (de) | Verfahren zur prüfung von immunokompetenz |